Agilent exercises option to acquire remaining 52% in Lasergen for $105mm
Drug Discovery Tools
- Molecular Diversity
- Drug Discovery Tools
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Research, Analytical Equipment & Supplies
- Payment Includes Cash
- Acquisition of Private Biotech
- Intra-Biotech Deal
- Partial Acquisition
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.